Purification and Structural Characterization of Aggregation-Prone Human TDP-43 Involved in Neurodegenerative Diseases
Gareth S.A. Wright,
Tatiana F. Watanabe,
Kangsa Amporndanai,
Steven S. Plotkin,
Neil R. Cashman,
Svetlana V. Antonyuk,
S. Samar Hasnain
Affiliations
Gareth S.A. Wright
Molecular Biophysics Group, Department of Biochemistry & Systems Biology, Institute of Systems, Molecular and Integrative Biology, Faculty of Health and Life Sciences, Liverpool L69 7ZB, UK
Tatiana F. Watanabe
Molecular Biophysics Group, Department of Biochemistry & Systems Biology, Institute of Systems, Molecular and Integrative Biology, Faculty of Health and Life Sciences, Liverpool L69 7ZB, UK
Kangsa Amporndanai
Molecular Biophysics Group, Department of Biochemistry & Systems Biology, Institute of Systems, Molecular and Integrative Biology, Faculty of Health and Life Sciences, Liverpool L69 7ZB, UK
Steven S. Plotkin
Department of Physics & Astronomy, The University of British Columbia, Vancouver, BC, Canada
Neil R. Cashman
Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC V6T 2B5, Canada
Svetlana V. Antonyuk
Molecular Biophysics Group, Department of Biochemistry & Systems Biology, Institute of Systems, Molecular and Integrative Biology, Faculty of Health and Life Sciences, Liverpool L69 7ZB, UK
S. Samar Hasnain
Molecular Biophysics Group, Department of Biochemistry & Systems Biology, Institute of Systems, Molecular and Integrative Biology, Faculty of Health and Life Sciences, Liverpool L69 7ZB, UK; Corresponding author
Summary: Mislocalization, cleavage, and aggregation of the human protein TDP-43 is found in many neurodegenerative diseases. As is the case with many other proteins that are completely or partially structurally disordered, production of full-length recombinant TDP-43 in the quantities necessary for structural characterization has proved difficult. We show that the full-length TDP-43 protein and two truncated N-terminal constructs 1-270 and 1-263 can be heterologously expressed in E. coli. Full-length TDP-43 could be prevented from aggregation during purification using a detergent. Crystals grown from an N-terminal construct (1-270) revealed only the N-terminal domain (residues 1-80) with molecules arranged as parallel spirals with neighboring molecules arranged in head-to-tail fashion. To obtain detergent-free, full-length TDP-43 we mutated all six tryptophan residues to alanine. This provided sufficient soluble protein to collect small-angle X-ray scattering data. Refining relative positions of individual domains and intrinsically disordered regions against this data yielded a model of full-length TDP-43.